<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">Comprehensive Drug Analysis,Ur-791194</span><br/>Reviewed date:[REDACTED] 10:08:04 PM<br/>Interpretation:<br/>Performing Lab:Labcorp Clinical / Digital, [REDACTED][REDACTED][REDACTED] Phone - [REDACTED], Director - MDEnnis<br/>Notes/Report:</td></tr><tr><td ID="result1_attr1">Summary Report (Summary)</td><td>Note</td><td/><td ID="result1_attr1_notes"><p>====================================================================</p><p> Medication list was not provided.</p><p>====================================================================</p><p>  Creatinine              88               mg/dL</p><p>Test                      Result    Flag   Units      Ref Range</p><p>====================================================================</p><p>====================================================================</p><p>  NO DRUGS DETECTED.</p><p>====================================================================</p><p>For clinical consultation, please call [REDACTED].</p><p>Comprehensive Drug Analysis,Ur</p><p>Declared Medications:</p><p>Test                             Result       Flag       Units</p><p>====================================================================</p></td></tr><tr><td ID="result1_attr2">PDF</td><td>.</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">Comp. Metabolic Panel (14)-322000</span><br/>Reviewed date:[REDACTED] 01:00:02 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result2_attr1">Glucose</td><td>83</td><td>70-99 mg/dL</td><td/></tr><tr><td ID="result2_attr2">BUN</td><td>15</td><td>8-27 mg/dL</td><td/></tr><tr><td ID="result2_attr3">Creatinine</td><td>0.93</td><td>0.76-1.27 mg/dL</td><td/></tr><tr><td ID="result2_attr4">eGFR</td><td>87</td><td>&gt;59 mL/min/1.73</td><td/></tr><tr><td ID="result2_attr5">BUN/Creatinine Ratio</td><td>16</td><td>10-24</td><td/></tr><tr><td ID="result2_attr6">Sodium</td><td>142</td><td>134-144 mmol/L</td><td/></tr><tr><td ID="result2_attr7">Potassium</td><td>4.2</td><td>3.5-5.2 mmol/L</td><td/></tr><tr><td ID="result2_attr8">Chloride</td><td>106</td><td>96-106 mmol/L</td><td/></tr><tr><td ID="result2_attr9">Carbon Dioxide, Total</td><td>18</td><td>20-29 mmol/L</td><td/></tr><tr><td ID="result2_attr10">Calcium</td><td>8.6</td><td>8.6-10.2 mg/dL</td><td/></tr><tr><td ID="result2_attr11">Protein, Total</td><td>6.0</td><td>6.0-8.5 g/dL</td><td/></tr><tr><td ID="result2_attr12">Albumin</td><td>4.0</td><td>3.8-4.8 g/dL</td><td/></tr><tr><td ID="result2_attr13">Globulin, Total</td><td>2.0</td><td>1.5-4.5 g/dL</td><td/></tr><tr><td ID="result2_attr14">A/G Ratio</td><td>2.0</td><td>1.2-2.2</td><td/></tr><tr><td ID="result2_attr15">Bilirubin, Total</td><td>0.3</td><td>0.0-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">Alkaline Phosphatase</td><td>64</td><td>44-121 IU/L</td><td/></tr><tr><td ID="result2_attr17">AST (SGOT)</td><td>20</td><td>0-40 IU/L</td><td/></tr><tr><td ID="result2_attr18">ALT (SGPT)</td><td>23</td><td>0-44 IU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">Lipid Panel-303756</span><br/>Reviewed date:[REDACTED] 01:00:02 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result3_attr1">Cholesterol, Total</td><td>179</td><td>100-199 mg/dL</td><td/></tr><tr><td ID="result3_attr2">Triglycerides</td><td>52</td><td>0-149 mg/dL</td><td/></tr><tr><td ID="result3_attr3">HDL Cholesterol</td><td>80</td><td>&gt;39 mg/dL</td><td/></tr><tr><td ID="result3_attr4">VLDL Cholesterol Cal</td><td>10</td><td>5-40 mg/dL</td><td/></tr><tr><td ID="result3_attr5">LDL Chol Calc (NIH)</td><td>89</td><td>0-99 mg/dL</td><td/></tr><tr><td colspan="4"><span class="content_span">Albumin/Creatinine Ratio,Urine-140285</span><br/>Reviewed date:[REDACTED] 01:00:01 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result4_attr1">Creatinine, Urine</td><td>94.1</td><td>Not Estab. mg/dL</td><td/></tr><tr><td ID="result4_attr2">Albumin, Urine</td><td>3.0</td><td>Not Estab. ug/mL</td><td/></tr><tr><td ID="result4_attr3">Alb/Creat Ratio</td><td>3</td><td>0-29 mg/g creat</td><td ID="result4_attr3_notes"><p>                                      Moderately increased: 30 - 300</p><p>                                      Normal:                0 -  29</p><p>                                      Severely increased:       &gt;300</p></td></tr><tr><td colspan="4"><span class="content_span">Vitamin D, 25-Hydroxy-081950</span><br/>Reviewed date:[REDACTED] 01:00:01 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result5_attr1">Vitamin D, 25-Hydroxy</td><td>46.8</td><td>30.0-100.0 ng/mL</td><td ID="result5_attr1_notes"><p>   National Academies Press.</p><p>insufficiency as a level between 21 and 29 ng/mL (2).</p><p>   Evaluation, treatment, and prevention of vitamin D</p><p>   deficiency: an Endocrine Society clinical practice</p><p>level of serum 25-OH vitamin D less than 20 ng/mL (1,2).</p><p>The Endocrine Society went on to further define vitamin D</p><p>1. IOM (Institute of Medicine). 2010. Dietary reference</p><p>Vitamin D deficiency has been defined by the Institute of</p><p>   intakes for calcium and D. [REDACTED][REDACTED]: The</p><p>Medicine and an Endocrine Society practice guideline as a</p><p>   guideline. JCEM. [REDACTED]; 96(7):1911-30.</p><p>2. [REDACTED], [REDACTED] NC, [REDACTED] HA, et al.</p></td></tr><tr><td colspan="4"><span class="content_span">CBC, Platelet, No Differential-028142</span><br/>Reviewed date:[REDACTED] 01:00:01 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result6_attr1">WBC</td><td>5.3</td><td>3.4-10.8 x10E3/uL</td><td/></tr><tr><td ID="result6_attr2">RBC</td><td>4.41</td><td>4.14-5.80 x10E6/uL</td><td/></tr><tr><td ID="result6_attr3">Hemoglobin</td><td>14.3</td><td>13.0-17.7 g/dL</td><td/></tr><tr><td ID="result6_attr4">Hematocrit</td><td>42.6</td><td>37.5-51.0 %</td><td/></tr><tr><td ID="result6_attr5">MCV</td><td>97</td><td>79-97 fL</td><td/></tr><tr><td ID="result6_attr6">MCH</td><td>32.4</td><td>26.6-33.0 pg</td><td/></tr><tr><td ID="result6_attr7">MCHC</td><td>33.6</td><td>31.5-35.7 g/dL</td><td/></tr><tr><td ID="result6_attr8">RDW</td><td>12.8</td><td>11.6-15.4 %</td><td/></tr><tr><td ID="result6_attr9">Platelets</td><td>222</td><td>150-450 x10E3/uL</td><td/></tr><tr><td colspan="4"><span class="content_span">Prostate-Specific Ag-010322</span><br/>Reviewed date:[REDACTED] 01:00:02 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result7_attr1">Prostate Specific Ag</td><td>2.5</td><td>0.0-4.0 ng/mL</td><td ID="result7_attr1_notes"><p>According to the American Urological Association, Serum PSA should</p><p>interchangeably. Results cannot be interpreted as absolute evidence</p><p>PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory</p><p>PSA value 0.2 ng/mL or greater.</p><p>                                                                     .</p><p>decrease and remain at undetectable levels after radical</p><p>prostatectomy. The AUA defines biochemical recurrence as an initial</p><p>Roche ECLIA methodology.</p><p>Values obtained with different assay methods or kits cannot be used</p><p>of the presence or absence of malignant disease.</p></td></tr><tr><td colspan="4"><span class="content_span">Lipase-001404</span><br/>Reviewed date:[REDACTED] 01:00:01 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result8_attr1">Lipase</td><td>27</td><td>13-78 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">Vitamin B12 and Folate-000810</span><br/>Reviewed date:[REDACTED] 01:00:00 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result9_attr1">Vitamin B12</td><td>268</td><td>232-1245 pg/mL</td><td/></tr><tr><td ID="result9_attr2">Folate (Folic Acid), Serum</td><td>8.3</td><td>&gt;3.0 ng/mL</td><td ID="result9_attr2_notes"><p>A serum folate concentration of less than 3.1 ng/mL is</p><p>considered to represent clinical deficiency.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>New patient</td></tr><tr><th>Diagnosis 1</th><td>Screening for malignant neoplasm of colon (Z12.11)</td></tr><tr><th>Referral Organization</th><td>MCM Clearwater [REDACTED].</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>Advanced Gastroenterology Associates, [REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Gastroenterology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:04:39 PM &gt;printed out for patient to schedule</td></tr><tr><th>Clinical Notes</th><td>[REDACTED] [REDACTED] 04:42:15 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>New patient | [REDACTED]</td></tr><tr><th>Diagnosis 1</th><td>Essential (primary) hypertension (I10)</td></tr><tr><th>Diagnosis 2</th><td>Poor visual fixation (R29.818)</td></tr><tr><th>Diagnosis 3</th><td>Hypertensive retinopathy, bilateral (H35.033)</td></tr><tr><th>Referral Organization</th><td>MCM Clearwater [REDACTED].</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED] Eye, Inc</td></tr><tr><th>Referred Provider Specialty</th><td>Optometrist</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:03:22 PM &gt;printed for patient to schedule</td></tr><tr><th>Clinical Notes</th><td>[REDACTED] [REDACTED] 11:04:29 AM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">amLODIPine Besylate 5 MG</td><td ID="instruction1">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">hydroCHLOROthiazide 12.5 MG</td><td ID="instruction2">1 tablet in the morning Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Losartan Potassium 100 MG</td><td ID="instruction3">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div>No Information</div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>1234779007</td><td ID="Problem1">Alcohol abuse with alcohol-induced mood disorder (F10.14)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>6962006</td><td ID="Problem2">Hypertensive retinopathy, bilateral (H35.033)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>59621000</td><td ID="Problem3">Essential (primary) hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div>No Information</div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Clearwater [REDACTED].</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>MCM Clearwater [REDACTED].</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Encounter to establish care with new doctor Z76.89 ; Essential (primary) hypertension I10 ; ENCOUNTER FOR PROSTATE CANCER SCREENING Z12.5 ; Screening for malignant neoplasm of colon Z12.11 ; SCREENING FOR LIPID DISORDERS Z13.220 ; Encounter for vitamin deficiency screening Z13.21 ; Alcohol abuse with alcohol-induced mood disorder F10.14 and Hypertensive retinopathy, bilateral H35.033</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td>Continue all current medications</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Encounter to establish care with new doctor (ICD-10 - Z76.89)</td><td/><td><p>Medical records requested for reviewed</p><p>Pending referrals:</p><p>-colonoscopy</p><p>-Ophthalmology</p></td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>ENCOUNTER FOR PROSTATE CANCER SCREENING (ICD-10 - Z12.5)</td><td/><td>Labs ordered</td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Screening for malignant neoplasm of colon (ICD-10 - Z12.11)</td><td/><td>Referral to gastroenterologist</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>SCREENING FOR LIPID DISORDERS (ICD-10 - Z13.220)</td><td/><td>Labs ordered</td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Encounter for vitamin deficiency screening (ICD-10 - Z13.21)</td><td/><td>abs ordered</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Alcohol abuse with alcohol-induced mood disorder (ICD-10 - F10.14)</td><td/><td>Labs ordered</td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Hypertensive retinopathy, bilateral (ICD-10 - H35.033)</td><td/><td>Referral sent</td><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 10:40:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Wellcare Medicare HMO CAP</td><td>PO BOX [REDACTED]</td><td>[REDACTED]</td><td>36888559</td><td>FL103</td><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>KIDNEY STONES</td><td/></tr><tr><td>HYPERTENSION</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>vasectomy</td><td>?</td></tr></tbody></table></div><br/><br/>
</body></html>